Home > Insider Trading > Filing (0000950142-13-002123)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368514	Adma Biologics Inc.	ADMA	Biological Products, (No Disgnostic Substances) (2836)	562590442

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1172252	N Andrew Schiff	888 Seventh Avenue 30Th Floor New York NY 10106	No	No	Yes	No
1250195	Steve Elms	888 Seventh Avenue 30Th Floor New York NY 10106	No	No	Yes	No
1297291	J Dennis Purcell	888 Seventh Avenue 30Th Floor New York NY 10106	No	No	Yes	No
1350778	Aisling Capital Ii Lp	888 Seventh Avenue 30Th Floor New York NY 10106	No	No	Yes	No
1376171	Aisling Capital Partners Llc	888 Seventh Avenue 30Th Floor New York NY 10106	No	No	Yes	No
1376172	Aisling Capital Partners, Lp	888 Seventh Avenue 30Th Floor New York NY 10106	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-10-22	411,765	$8.50	3,620,143	No	4	P	Indirect	By Aisling Capital II, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Aisling Capital II, LP

Footnotes

After giving effect to the stock split at a ratio of 1.27-for-1 effected by ADMA Biologics, Inc. on April 4, 2013.
The reportable securities are owned directly by Aisling Capital II, LP ("Aisling"), and held indirectly by Aisling Capital Partners, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling.